Clinical Trial

Repositioning the Bolus Tracking ROI to the Superior Vena Cava in CTPA Facilitates Contrast Volume Reduction

Completed
View on ClinicalTrials.gov →
Summary
This randomized controlled trial evaluates a protocol optimization for Computed Tomography Pulmonary Angiography (CTPA). The study investigates the impact of repositioning the bolus-tracking region-of-interest (ROI) from the standard pulmonary trunk (PT) to the superior vena cava (SVC). The goal is to compensate for the CT scanner's inherent transit delay time (TDT) to better align the scan with the peak arterial phase. By optimizing this timing, the study assesses whether contrast media volume can be safely reduced by 40% (from 50 ml to 30 ml) while maintaining diagnostic image quality and preventing venous contamination.
Trial Details
NCT Number NCT07342374
Lead Sponsor Hospital Queen Elizabeth, Malaysia
Collaborators: Universiti Sultan Zainal Abidin
Conditions Pulmonary Artery Embolism, Pulmonary Embolism (PE)
Enrollment 72 participants
Start Date 2023-02-01
Primary Completion 2024-12-16 (estimated)
Study Completion 2024-12-16 (estimated)
Updated on ClinicalTrials.gov 2026-01-15